Related Experiment Videos
Lipids, risk factors and ischaemic heart disease
1Framingham Cardiovascular Institute, MA 01701-9167, USA.
Insights
Identifying abnormal lipid profiles is crucial for cardiovascular disease (CVD) risk. Simple tests for cholesterol and triglyceride levels help pinpoint individuals needing early intervention to prevent coronary heart disease (CHD).
Area of Science:
- Cardiology
- Biochemistry
- Preventive Medicine
Background:
- Over 200 risk factors for cardiovascular disease (CVD) are known.
- Key factors include abnormal lipids, hypertension, and smoking.
- Other contributors include diabetes, haemostatic factors, apolipoprotein E4, and homocysteine.
Purpose of the Study:
- To highlight the significance of lipid profiles in CVD risk assessment.
- To emphasize the need for early identification and treatment of individuals with atherogenic lipid profiles.
Main Methods:
- Assessing the ratio of total cholesterol to high-density lipoprotein (HDL) cholesterol.
- Measuring plasma triglyceride concentrations.
- Differentiating the primary lipid abnormality (LDL, HDL, or triglyceride-rich particles).
Main Results:
- Abnormal lipid profiles, characterized by specific cholesterol and triglyceride levels, are major contributors to CVD.
- Simple lipid tests can identify individuals at increased risk for CVD.
- Early detection of high lipid risk profiles allows for timely intervention.
Conclusions:
- Maintaining correct proportions of circulatory factors is essential for low CVD risk.
- Lipid testing is a vital tool for identifying individuals at high risk for CVD.
- Proactive treatment of identified high lipid risk profiles can prevent coronary heart disease (CHD).
Abstract:
Over 200 risk factors for cardiovascular disease (CVD) have now been identified. Among these, the three most important are (1) abnormal lipids, including the fact that there are more than 15 types of cholesterol-containing lipoproteins and four different types of triglyceride-rich particles, some of which are very atherogenic, (2) high blood pressure, and (3) cigarette smoking. In addition, many other factors including diabetes, haemostatic factors such as fibrinogen, factor VII, plasminogen activator inhibitors, and new factors such as apolipoprotein E4 and homocysteine, are known to increase the risk of developing clinical CVD. A low risk for CVD requires that these various factors are present in the circulation in the correct proportions. Two simple tests for determining plasma lipid levels can be used to identify those individuals with an atherogenic lipid profile and who are, therefore, at increased risk for CVD. Firstly, the ratio of total cholesterol to high density cholesterol (HDL cholesterol) should be determined, followed by measurement of plasma triglyceride concentrations. This will allow differentiation of whether the low density lipoproteins (LDL), HDL cholesterol or triglyceride-rich particles such as the small dense beta-very low density lipoproteins (VLDL) are the major cause for concern. Once identified, those individuals with a high lipid risk profile should be treated before, rather than after, experiencing coronary heart disease (CHD).